TY  - CHAP
AU  - Vinod Chainani
AU  - Russell Riehl
AU  - Geeta Chainani
AU  - Abir Abdo
AU  - Mauricio
G. Cohen
AU  - Carlos Alfonso
AU  - Pedro Martinez‐Clark
AU  - Carl J. Lavie
AU  - John P.
Reilly
AU  - Nidal Abi‐Rafeh
ED  - Yannis Dionyssiotis
Y1  - 2017-08-30
PY  - 2017
T1  - Frailty and Cardiovascular Disease
N2  - Frailty is considered a multisystem impairment that makes an individual vulnerable to external or internal stressors. Sarcopenia, the age-dependent loss of muscle mass and function, is proposed as the biological substrate and the pathway whereby the consequences of physical frailty develop. These syndromes are associated with a negative impact in quality of life and can lead to the occurrence of disability, institutionalization, and even mortality. The book focuses upon all the related aspects of frailty and sarcopenia and the new advancements in the related treatments including complex issues and research. It includes high-quality chapters in all related aspects for the syndromes of sarcopenia and frailty, which adversely affect the function and overall effectiveness of the musculoskeletal system and interventions to promote rehabilitation.
BT  - Frailty and Sarcopenia
SP  - Ch. 10
UR  - https://doi.org/10.5772/intechopen.69877
DO  - 10.5772/intechopen.69877
SN  - 978-953-51-3484-8
PB  - IntechOpen
CY  - Rijeka
Y2  - 2024-05-09
ER  -